Mr. Michael Burt at the Environment and Sustainable Development Committee

On June 14th, 2016. See this statement in context.

June 14th, 2016 / 12:20 p.m.

Corporate Director, Regulatory and Government Affairs, Dow Chemical Canada Inc.

Yes, we are in support of looking at the mode of transport when it comes to endocrine disrupters. We think the CMP and CEPA currently do look at the risk assessment. If there are vulnerable populations, then they should be taken into consideration when it comes to the risk assessment.

See context to find out what was said next.